Raptor Pharmaceutical’s investigational Huntington’s disease drug helped delay the progression of the brain-deteriorating disorder in a subset of patients, the company said, news that sent the biotech’s shares soaring despite some lingering concerns with the data.

…read more

Source: Raptor jumps as its Huntington’s hopeful slows the loss of muscle control


0 No comments